Huilun Pharmaceutical Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 1,420

Employees

  • Latest Deal Type
  • IPO
  • (Announced)

  • Investors
  • 12

Huilun Pharmaceutical General Information

Description

Developer and manufacturer of innovative pharmaceutical products designed for oncology, immunology, inflammation, pain management, and chronic disease treatments. The company provides a portfolio of proprietary Class I innovative drugs, improved formulations, and first-generic medicines, enabling healthcare providers and patients with safe, effective, and high-clinical-value therapies that address unmet medical needs.

Contact Information

Website
www.huilun.com
Formerly Known As
Shanghai Huilun Biotechnology Co., Ltd., Shanghai Huilun Life Technology Co., Ltd.
Ownership Status
In IPO Registration
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 1001-1002, Phase II, Greenland Center
  • No. 562 Dong'an Road, Xuhui District
  • Shanghai, 200241
  • China
+86 021
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Corporate Office
  • Room 1001-1002, Phase II, Greenland Center
  • No. 562 Dong'an Road, Xuhui District
  • Shanghai, 200241
  • China
+86 021

Huilun Pharmaceutical Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Huilun Pharmaceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. IPO 02-Apr-2026 Announced Generating Revenue
13. Later Stage VC (Series I) 22-Aug-2025 Completed Generating Revenue
12. Secondary Transaction - Private 21-Aug-2025 Completed Generating Revenue
11. Secondary Transaction - Private 01-Oct-2024 Completed Generating Revenue
10. Later Stage VC (Series H) 21-Oct-2024 Completed Generating Revenue
9. Merger/Acquisition 23-Feb-2024 Cancelled Generating Revenue
8. Later Stage VC (Series G) 28-Nov-2022 Completed Generating Revenue
7. Later Stage VC (Series F) 15-Dec-2021 Completed Generating Revenue
6. Secondary Transaction - Private 01-Nov-2021 $139M Completed Generating Revenue
5. Later Stage VC (Series E) 01-Apr-2021 $52.9M $139M Completed Generating Revenue
To view Huilun Pharmaceutical’s complete valuation and funding history, request access »

Huilun Pharmaceutical Patents

Huilun Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026189513-A1 Pharmaceutical salt of sulfonamide compound, crystal form of salt, composition, and use Pending 14-Mar-2025
EP-4837908-A1 Novel sodium channel modulator compound and use thereof Pending 23-Jan-2025
WO-2026139098-A1 Pharmaceutical combination and use thereof in treatment of acne Pending 26-Dec-2024
WO-2026109030-A1 Piperidine ring compound, pharmaceutical composition thereof, and use thereof Pending 25-Nov-2024
WO-2026067901-A1 Topical pharmaceutical composition Pending 30-Sep-2024
To view Huilun Pharmaceutical’s complete patent history, request access »

Huilun Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Huilun Pharmaceutical Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Guizhou Financial Holdings Group Government Minority
Gaoxin Capital Growth/Expansion Minority
Kangcheng Capital Growth/Expansion Minority
Shanghai Tianzi Investment Management Growth/Expansion Minority
Wanlian Tianze Capital Investment Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Huilun Pharmaceutical FAQs

  • When was Huilun Pharmaceutical founded?

    Huilun Pharmaceutical was founded in 2004.

  • Where is Huilun Pharmaceutical headquartered?

    Huilun Pharmaceutical is headquartered in Shanghai, China.

  • What is the size of Huilun Pharmaceutical?

    Huilun Pharmaceutical has 1,420 total employees.

  • What industry is Huilun Pharmaceutical in?

    Huilun Pharmaceutical’s primary industry is Biotechnology.

  • Is Huilun Pharmaceutical a private or public company?

    Huilun Pharmaceutical is a Private company.

  • What is Huilun Pharmaceutical’s current revenue?

    The current revenue for Huilun Pharmaceutical is .

  • How much funding has Huilun Pharmaceutical raised over time?

    Huilun Pharmaceutical has raised $213M.

  • Who are Huilun Pharmaceutical’s investors?

    Guizhou Financial Holdings Group, Gaoxin Capital, Kangcheng Capital, Shanghai Tianzi Investment Management, and Wanlian Tianze Capital Investment are 5 of 12 investors who have invested in Huilun Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process